PENMENVY, GSK's 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWY
1. GSK's PENMENVY vaccine gains FDA approval for MenABCWY protection. 2. This approval enhances GSK's vaccine portfolio, potentially driving future revenue.